Qingdao Baheal Pharmaceutical Holdings Limited’s Net Profit Rose 38.7% in First Quarter of 2023

Qingdao Baheal Pharmaceutical Holdings Limited (青岛百洋医药股份有限公司) (301015.SZ) reported a net profit of 119.5 million yuan in the first quarter of 2023, up 38.7% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 9.3% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 52.8%.